H
Power Law company profile
Haihe Biopharma
Biotech & Life Sciences · Huangpu, China · Founded 2011 Unicorn
Global footprint
Where Haihe Biopharma has talent and traffic
AI talent share
3.4%
of workforce is AI talent
(1 of 29 staff)
(1 of 29 staff)
Core AI00%
Other AI13.45%
Non-AI workforce2896.55%
Web traffic by country
4.4K
monthly visits
across markets
across markets
🇨🇳 China63.6%
🇯🇵 Japan34.1%
🇺🇸 United States2.3%
Patent intelligence
$45M patent portfolio · 46 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$45M
4.5% of valuation · 5.1× smaller than top peer Galapagos ($230M)
46 active patent families
Where Haihe Biopharma innovates
Pharmaceutical drugDiseasePharmacologyMedicinal chemistryPharmaceutical medicine
Above peer median on Market, Economic, Technology · Below peer median on Strategic
Quality vs same-sector peers
Haihe Biopharma on the five Patsnap quality dimensions
Haihe Biopharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Haihe Biopharma concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Haihe Biopharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Haihe Biopharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.